California Proposal to Lure Fledgling Stem Cell and Gene Therapy Companies
Multimillion dollar enticements being considered by state agency
Directors of the $12 billion California stem cell agency will consider a plan on Wednesday to strengthen its support of emerging companies, expand its portfolio and effectively increase the size of its awards.
The proposal would further cement the agency’s and the state of California’s role as an early-stage “angel” investor in fledgling stem cell and g…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.